Survivin expression in acute leukemias and myelodysplastic syndromes

Leukemia and Lymphoma

Volumn 45, Issue 11, 2004, Pages 2229-2237

  Invernizzi, Rosangela ^a   Travaglino, Erica ^a   Lunghi, Monia ^a   Klersy, Catherine ^b   Bernasconi, Paolo ^a   Cazzola, Mario ^a   Ascari, Edoardo ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Acute leukemia; Apoptosis; Immunocytochemistry; Myelodysplastic syndrome; Survivin

Indexed keywords

CYTARABINE; ETOPOSIDE; IDARUBICIN; SURVIVIN;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; BLAST CELL; BONE MARROW CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CELL COUNT; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INCIDENCE; KARYOTYPE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MYELODYSPLASTIC SYNDROME; NICK END LABELING; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REFRACTORY ANEMIA; REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS;

APOPTOSIS; BONE MARROW CELLS; CELL DEATH; CELL PROLIFERATION; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LEUKEMIA, MYELOCYTIC, ACUTE; MICROTUBULE-ASSOCIATED PROTEINS; MYELODYSPLASTIC SYNDROMES; NEOPLASM PROTEINS; TIME FACTORS;

EID: 8644241716     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190412331283251     Document Type: Article

References (50)

1. Ambrosini, G., Adida, C. and Altieri, D.C. (1997) "A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma", Nature Medicine, 3, 917-921.
2. Ambrosini, G., Adida, C., Sirugo, G. and Altieri, D.C. (1998) "Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting", Journal of Biological Chemistry, 273, 11177-11182.
3. Li, F., Ambrosini, G., Chu, E.Y., Plescia, J., Tognin, S., Marchisio, P.C., et al. (1998) "Control of apoptosis and mitotic spindle checkpoint by surviving", Nature, 396, 580-584.
4. Lu, C.D., Altieri, D.C. and Tanigawa, N. (1998) "Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas", Cancer Research, 58, 1808-1812.
5. Adida, C., Recher, C., Raffoux, E., Daniel, M.T., Taksin, A.L., Rousselot, P., et al. (2000) "Expression and prognostic significance of survivin in de novo acute myeloid leukemia", British Journal of Hematology, 111, 196-203.
6. Carter, B.Z., Milella, M., Altieri, D.C. and Andreeff, M. (2001). "Cytokine-regulated expression of survivin in myeloid leukemia", Blood, 97, 2784-2790.
7. Gianani, R., Jarboe, E., Orlicky, D., Frost, M., Bobak, G., Lehner, R., et al. (2001) "Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosa", Human Pathology, 32, 119-125.
8. Satoh, K., Kaneko, K., Hirota, M., Masamune, A., Satoh, A. and Shinosegawa, T. (2001) "Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors", Cancer, 92, 271-278.
9. Adida, C., Berrei, D., Peuchmaur, M., Reyes-Mugica, M. and Altieri, D.C. (1998) "Anti-apoptosis gene, survivin, and prognosis of neuroblastoma", Lancet, 351, 882-883.
10. Adida, C., Haioun, C., Gaulard, P., Lepade, E., Morel, P., Briere, J., et al. (2000) "Prognostic significance of survivin expression in diffuse large B-cell lymphomas", Blood, 96, 1921-1925.
11. Kawasaki, H., Altieri, D.C., Lu, C.D., Toyoda, M., Tenjo, T. and Tanigawa, N. (1998) "Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer", Cancer Research, 58, 5071-5074.
12. Tanaka, K., Iwamoto, S., Gon, G., Nohara, T., Iwamoto, M. and Tanigawa, N. (2000) "Expression of survivin and its relationship to loss of apoptosis in breast carcinomas", Clinical Cancer Research, 6 127-134.
13. Negoescu, A., Lorimier, P., Labat-Moleur, F., Drouet, C., Robert, C., Guillermet, C., et al. (1996) "In situ apoptotic cell labeling by the TUNEL method: improvement and evaluation on cell preparations", The Journal of Histochemistry and Cytochemistry, 44, 959-968.
14. Rowan, S. and Fisher, D.E. (1997) "Mechanism of apoptotic cell death", Leukemia, 11, 457-465.
15. Devereaux, Q.L., Takahashi, R., Salvesen, G.S. and Reed, J.C. (1997) "X-linked IAP is a direct inhibitor of cell-death proteases", Nature, 388, 300-304.
16. Tamm, I., Wang, Y., Sausville, E., Scudiero, D.A., Vigna, N., Oltersdorf, T., et al. (1998) "IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs", Cancer Research, 58, 5315-5320.
17. Reed, J.C. (1999) "Dysregulation of apoptosis in cancer", Journal of Clinical Oncology, 17, 2941-2953.
18. Parker, J.E. and Mufti, G.J. (1998) "Inefective hemopoiesis and apoptosis in myelodysplastic syndromes", British Journal of Hematology, 101, 220-230.
19. Yoshida, Y. and Mufti, G.J. (1999) "Apoptosis and its significance in MDS: controversies revisited", Leukemia Research, 23, 777-785.
20. Parker, J.E., Mufti, G.J., Rasool, F., Mijovic, A., Devereux, S. and Pagliuca, A. (2000) "The role of apoptosis, proliferation, and Bcl-2-related proteins in the myclodysplastic syndromes and acute myeloid leukemia secondary to MDS", Blood, 96, 3932-3938.
21. Rosenfeld, C. and List, A. (2000) "A hypothesis for the pathogenesis of myelodysplastic syndromes: implications for new therapies", Leukemia, 14, 2-8.
22. Invernizzi, R., Pecci, A., Bellotti, L. and Ascari, E. (2001) "Expression of p53, Bcl-2 and Ras oncoproteins and apoptosis levels in acute leukemias and myelodysplastic syndromes", Leukemia and Lymphoma 42, 481-489.
23. Pecci, A., Travaglino, E., Klersy, C. and Invernizzi, R. (2003) "Apoptosis in relation to CD34 antigen expression in normal and myelodysplastic bone marrow", Acta Hematologica, 109, 29-34.
24. Rajapaksa, R., Ginzton, N., Rott, L.S. and Greenberg, P.L. (1996) "Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells", Blood, 88, 4275-4287.
25. Hellstrom-Lindberg, E., Kanter-Lewensohn, L. and Ost, A. (1997) "Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte-CSF and erythropoietin", Leukemia Research, 21, 415-425.
26. Tsoplou, P., Kouraklis-Symeonidis, A., Thanopoulou, E., Zikos, P., Orphanos, V. and Zoumbos, N.C. (1999) "Apoptosis in patients with myelodysplastic syndromes: differential involvement of marrow cells in 'good' versus 'poor' prognosis patients and correlation with apoptosis-related genes", Leukemia, 13, 1554-1563.
27. Invernizzi, R. (2002) "The role of apoptosis in myelodysplastic syndrome", Hematologica, 87, 337-339.
28. Li, F., Ackermann, E.J., Bennett, C.F., Rothermel, A.L., Plescia, J., Tognin, S., et al. (1999) "Pleiotropic cell-division defects and apoptosis induced by interference with survivin function", Nature Cell Biology, 1, 461-466.
29. Kobayashi, K., Hatano, M., Otaki, M., Ogasawara, T. and Tokuhisa, T. (1999) "Expression of a marine homologue of the inhibitor of apoptosis protein is related to cell proliferation", Proceedings National Academy of Science USA, 96, 1457-1462.
30. Fortugno, P., Wall, N.R., Giodini, A., O'Connor, D.S., Plescia, J., Padgett, K.M., et al. (2002) "Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function", Journal of Cell Science, 115, 575-585.
31. Fukuda, S. and Pelus, L.M. (2001) "Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34 + cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis", Blood, 98, 2091-2100.
32. Velculescu, V.E., Madden, S.L., Zhang, L., Lash, A.E., Yu, J., Rago, C., et al. (1999) "Analysis of human transcriptomes", Nature Genetics, 23, 387-388.
33. Shinozawa, I., Inokuchi, K., Wakabayashi, I. and Dan, K. (2000) "Disturbed expression of the anti-apoptosis gene, Survivin, and EPR-1 in hematological malignancies", Leukemia Research, 24, 965-970.
34. Granziero, L., Ghia, P., Circosta, P., Gottardi, D., Strola, G., Geuna, M., et al. (2001) "Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic, leukemia", Blood, 97, 2777-2783.
35. Moriai, R., Asanuma, K., Kobayashi, D., Yajima, T., Yagihashi, A., Yamada, M. and Watanabe, N. (2001) "Quantitative analysis of the anti-apoptotic gene survivin expression in malignant hematopoietic cells", Anticancer Research, 21, 595-600.
36. Mori, A., Wada, H., Nishimura, Y., Okamoto, T., Takemoto, Y. and Kakishita, E. (2002) "Expression of the antiapoptosis gene survivin in human leukemia", International Journal of Hematology, 75, 161-165.
37. Nakayama, K. and Kamihira, S. (2002) "Survivin an important determinant for prognosis in adult T-cell leukemia: a novel biomarker in practical hemato-oncology", Leukemia and Lymphoma, 43, 2249-2255.
38. Altieri, D.C. and Marchisio, C. (1999) "Survivin apoptosis: an interloper between cell death and cell proliferation in cancer", Laboratory Investigation, 79, 1327-1333.
39. Kim, P.J., Plescia, J., Clevers, H., Fearon, E.R. and Altieri, D.C. (2003) "Survivin and molecular pathogenesis of colorectal cancer", Lancet, 362, 205-209.
40. Grossman, D., Kim, P.J., Schechner, J.S. and Altieri, D.C. (2001) "Inhibition of melanoma tumor growth in vivo by survivin targeting", Proceedings National Academy of Science USA, 98, 635-640.
41. Altieri, D.C. (2003) "Validating survivin as a cancer therapeutic target", Nature Reviews Cancer, 3, 46-54.
42. Blanc-Brude, O.P., Mesri, M., Wall, N.R., Plescia, J., Dohi, T. and Altieri, D.C. (2003) Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis. Clinical Cancer Research, 9, 2683-2692.
43. Schmidt, S.M., Schag, K., Mueller, M.R., Weck, M.M., Appel, S., Kanz, L., et al. (2003) "Survivin is a shared tumor associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T-cells", Blood, 102, 571-576.
44. Campos, L., Sabido, O., Viallet, A., Vasselon, C. and Guyotat, D. (1999) "Expression of apoptosis-controlling proteins in acute leukemia cells", Leukemia and Lymphoma, 33, 499-509.
45. Badran, A., Yoshida, A., Wano, Y., Mutoh, M., Imamura, S., Yamashita, T., et al. (2003) "Expression of the anti-apoptotic gene survivin in myelodysplastic syndrome", International Journal of Oncology, 22, 59-64.
46. Raza, A., Mundle, S., Iftikhar, A., Gregory, S., Marcus, B., Khan, Z., et al. (1995) "Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis", American Journal of Hematology, 48, 143-154.
47. Shimazaki, K., Ohshima, K., Suzumiya, J., Kawasaki, C. and Kikuchi, M. (2000) "Evaluation of apoptosis as a prognostic factor in myelodysplastic syndromes", British Journal of Hematology, 110 584-590.
48. Albitar, M., Manshouri, T., Shen, Y., Liu, D., Beran, M., Kantarjian, H.M., et al. (2002) "Myelodysplastic syndrome is not merely 'preleukemia"', Blood, 100, 791-798.
49. Huh, Y.O., Jilani, I., Estey, E., Giles, F., Kantarjian, H., Freireich, E., et al. (2002) "More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemia", Leukemia, 16, 2249-2252.
50. Blanc-Brude, O.P., Yu, J., Simosa, H., Conte, M.S., Sessa, W.C. and Altieri, D.C. (2002) "Inhibitor of apoptosis protein survivin regulates vascular injury", Nature Medicine, 8, 987-994.